Skip to main content
Lunesta (Eszopiclone): Side Effects, Risks and Why Doctors Limit It
SLEEP

Lunesta (Eszopiclone): Side Effects, Risks and Why Doctors Limit It

Eszopiclone (Lunesta) is approved for insomnia. Here is what the FDA label says about dosing and side effects, including its unpleasant taste, why the FDA added a boxed warning in 2019 and lowered the starting dose in 2014, and why the Beers Criteria advise older adults to avoid it.

The Zest Team
The Zest Team

· 6 min read

Eszopiclone is the generic name for Lunesta, a prescription sleeping pill approved by the FDA in 2004 for insomnia, helping people fall asleep and stay asleep. It is a sedative-hypnotic, or Z-drug, now marketed by Waylis Therapeutics. It can help some people, but it carries an FDA boxed warning for complex sleep behaviors, and next-day impairment led the FDA to lower its starting dose.
Here is what the label says about dosing, what the trials found, its best-known side effect (an unpleasant taste), and the risks behind sleep specialists' caution. This is educational information, not medical advice; talk to a licensed clinician before starting or stopping any medication.

Lunesta at a glance

Generic nameEszopiclone
Brand nameLunesta (Waylis Therapeutics)
Drug classSedative-hypnotic (nonbenzodiazepine, a "Z-drug")
FDA approvalDecember 15, 2004, for insomnia; shown to shorten time to fall asleep and improve staying asleep
Controlled substanceYes, DEA Schedule IV
Strengths1, 2 and 3 mg tablets
Usual dose1 mg immediately before bed, with 7–8 hours left before waking; up to 3 mg if needed (2 mg maximum over 65)
Half-lifeAbout 6 hours (about 9 hours at 65 and older); peak about 1 hour after a dose
Boxed warningComplex sleep behaviors, such as sleep-walking and sleep-driving
Not forAnyone who has had a complex sleep behavior on eszopiclone, or is allergic to it
Generic availableYes

How does Lunesta work?

The label says eszopiclone's exact mechanism is unclear, but it likely acts on GABA receptor complexes near the benzodiazepine binding site, boosting GABA, the brain's main "brake" signal. It is chemically unrelated to benzodiazepines but shares some of their properties. It is the S-isomer of an older sleep drug, zopiclone.
Dual orexin receptor antagonists (DORAs) take a different route, blocking orexin, the brain's "stay awake" signal. See our guide to DORAs and Quviviq (daridorexant).

How to take Lunesta (dosage)

  • The FDA label's recommended starting dose is 1 mg, taken immediately before bed, with at least 7–8 hours before you plan to wake. The same starting dose applies to women and men.
  • A prescriber can raise it to 2 or 3 mg if needed. The maximum is 3 mg a night.
  • Adults over 65 and people who are debilitated should not exceed 2 mg. The same 2 mg cap applies to severe liver impairment and to people taking strong CYP3A4 inhibitors such as ketoconazole.
  • A heavy, high-fat meal slows absorption and can delay its effect.
  • Take it immediately before bed; the label says taking it while still up and about can cause memory lapses, hallucinations and poor coordination.
  • Do not take it if you drank alcohol that evening or before bed.

Does Lunesta work? What the trials found

In a 6-month trial published in Sleep in 2003, 593 adults took eszopiclone 3 mg and 195 took placebo nightly. Eszopiclone improved time to fall asleep, time awake during the night, total sleep and sleep quality at every monthly check, with no evidence of tolerance. The most common side effects were unpleasant taste and headache.
Across the Z-drug class, a 2012 BMJ meta-analysis of FDA trial data found the drugs shortened time to fall asleep in the sleep lab by about 22 minutes versus placebo, an effect the authors called small and of questionable clinical importance.

Lunesta side effects and risks

In the label's 6-week trial in adults:
Side effectPlaceboLunesta 2 mgLunesta 3 mg
Unpleasant taste3%17%34%
Headache13%21%17%
Sleepiness3%10%8%
Dizziness4%5%7%
Dry mouth3%5%7%
If you have searched "Lunesta metallic taste," the label's term is simply unpleasant taste, and it was the side effect most clearly tied to dose. The larger risks are in the warnings:
  • Complex sleep behaviors (boxed warning). Sleep-walking, sleep-driving, cooking or making calls while not fully awake, usually with no memory of it. Some events caused serious injury or death. The FDA required this boxed warning for eszopiclone, zolpidem and zaleplon in 2019. It can happen after the first dose, at recommended doses, with or without alcohol.
  • Next-day impairment. In a label study of healthy adults, 3 mg impaired driving-related coordination and memory the next morning, worst at 7.5 hours and still present at 11.5 hours, and people did not reliably feel impaired. In 2014 the FDA lowered the starting dose from 2 mg to 1 mg for this reason. The label cautions people taking 3 mg against next-day driving.
  • Dependence and withdrawal. Trials showed no serious withdrawal syndrome, but anxiety, abnormal dreams and upset stomach were reported after stopping. The label says the risk of abuse and dependence rises with dose and length of use.
  • Alcohol and other sedatives, including opioids, add to its effects.
  • Also: abnormal thinking or behavior, worsening depression, and severe allergic reactions.
Don't stop a sleep medication suddenly, especially a benzodiazepine; withdrawal can be serious. Talk to your prescriber about tapering.

Why doctors limit Lunesta, especially after 65

The label warns that eszopiclone raises the risk of falls, particularly in older adults, and people 65 and older clear it more slowly. The American Geriatrics Society's 2023 Beers Criteria advise older adults to avoid Z-drugs, including eszopiclone, citing delirium, falls, fractures, hospital visits and car crashes, with minimal improvement in sleep.
Card listing sleep medications the 2023 Beers Criteria say older adults should avoid: Z-drugs, benzodiazepines, first-generation antihistamines, and doxepin above 6 mg a day
Sleep medications the 2023 AGS Beers Criteria list as potentially inappropriate for adults 65 and older.

Eszopiclone vs. zolpidem

Lunesta (eszopiclone)Ambien (zolpidem)
Approved forInsomnia (falling and staying asleep)Short-term, trouble falling asleep (Ambien CR adds staying asleep)
Half-lifeAbout 6 hoursAbout 2.5 hours
Starting dose1 mg, women and men5 mg women; 5 or 10 mg men
Maximum dose3 mg10 mg (12.5 mg Ambien CR)
Boxed warningComplex sleep behaviorsComplex sleep behaviors
Controlled substanceSchedule IVSchedule IV
Generic availableYesYes
Eszopiclone lasts longer, which may help with staying asleep but leaves more drug in the morning. See our Ambien (zolpidem) guide.
Bar chart of prescription sleep medication half-lives from FDA labels: ramelteon 1 to 2.6 hours, zolpidem about 2.5, triazolam 1.5 to 5.5, eszopiclone about 6, daridorexant about 8, temazepam about 8.8, suvorexant about 12, doxepin 15.3, lemborexant 17 to 19
Half-lives of prescription sleep medications, from each drug's FDA label. Longer half-lives raise the chance of next-morning grogginess.

Alternatives to discuss with a clinician

Cognitive behavioral therapy for insomnia (CBT-I) is a structured, non-drug program for chronic insomnia. If medication is still needed, a clinician may discuss DORAs such as Belsomra (suvorexant) and Dayvigo (lemborexant). DORAs are not risk-free: they are also Schedule IV and share warnings such as next-day impairment and complex sleep behaviors.

How to get Lunesta prescribed

Eszopiclone is a controlled substance, so it needs a prescription from a licensed clinician after an evaluation of your sleep, health and medications. Good sleep habits and CBT-I come first; medication works best alongside them.

Zest RX for sleep. Zest is preparing to launch telehealth for sleep, connecting you with licensed providers who can evaluate whether a prescription option fits your needs. Join Zest RX early access.

Frequently asked questions

Is Lunesta a controlled substance?
Yes. Eszopiclone is a DEA Schedule IV controlled substance, the same schedule as zolpidem and benzodiazepines. It requires a prescription, and the label says the risk of dependence rises with dose and duration.
How long does Lunesta stay in your system?
Its half-life is about 6 hours, according to the FDA label, and about 9 hours in people 65 and older. That is why the label says to allow 7–8 hours in bed after a dose.
Why does Lunesta leave a bad taste?
The label lists unpleasant taste as the most common side effect, reported by 34% of adults on 3 mg versus 3% on placebo in one trial. It was more common at higher doses.
Can you take Lunesta with alcohol?
No. The label says not to take Lunesta if you drank alcohol that evening or before bed. Alcohol adds to eszopiclone's effect on coordination and raises the risk of impairment.
Is eszopiclone stronger than zolpidem?
The labels don't rank them by strength, and doses aren't interchangeable. Eszopiclone lasts longer (about 6 hours versus 2.5) and helps with staying asleep as well as falling asleep, while immediate-release zolpidem is approved for falling asleep.
Is there a generic for Lunesta?
Yes. FDA approval records list generic eszopiclone tablets from several manufacturers, including Dr. Reddy's, Mylan and Teva. Generics contain the same active ingredient as the brand.

Sources

  • LUNESTA (eszopiclone) prescribing information. DailyMed
  • FDA. Certain prescription insomnia medicines: new boxed warning. April 30, 2019. FDA
  • FDA. Drug Safety Communication on next-day impairment with Lunesta and a lower recommended dose, May 15, 2014 (Spanish-language version). FDA
  • 2023 AGS Beers Criteria Update Expert Panel. J Am Geriatr Soc. 2023;71(7):2052-2081. PubMed
  • Krystal AD, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment. Sleep. 2003;26(7):793-799. PubMed
  • Huedo-Medina TB, et al. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia. BMJ. 2012;345:e8343. PubMed
SLEEP
INSOMNIA
SLEEP MEDICATION

Related articles

Modafinil (Provigil) and Armodafinil (Nuvigil): Uses, Side Effects and How They Compare

SLEEP

Modafinil (Provigil) and Armodafinil (Nuvigil): Uses, Side Effects and How They Compare

Modafinil and armodafinil are Schedule IV wake-promoting drugs approved for excessive sleepiness from narcolepsy, sleep apnea and shift work disorder. Here is how they work, their dosage, side effects and label warnings, how they compare, and what the evidence says about off-label cognitive use.
The Zest Team
The Zest Team

· 7 min read

Ramelteon (Rozerem): How It Works, Dosage, Side Effects and vs. Melatonin

SLEEP

Ramelteon (Rozerem): How It Works, Dosage, Side Effects and vs. Melatonin

Ramelteon (Rozerem) is a prescription melatonin receptor agonist approved for trouble falling asleep, and it is not a controlled substance. Here is how it works, how it is taken, what the trials found, its side effects, and how it compares with melatonin.
The Zest Team
The Zest Team

· 6 min read

Doxepin for Sleep (Silenor): How Low-Dose Doxepin Works, Dosage and Side Effects

SLEEP

Doxepin for Sleep (Silenor): How Low-Dose Doxepin Works, Dosage and Side Effects

Low-dose doxepin (Silenor 3 mg and 6 mg) is FDA-approved for insomnia with trouble staying asleep, at a fraction of the antidepressant dose. Here is how it works, how it is taken, what the trials found, its side effects, and how it compares with trazodone.
The Zest Team
The Zest Team

· 6 min read